[go: up one dir, main page]

DK282384D0 - Malariaassocieret antigen, fremgangsmaade til fremstilling deraf og vaccine indeholdende antigenet - Google Patents

Malariaassocieret antigen, fremgangsmaade til fremstilling deraf og vaccine indeholdende antigenet

Info

Publication number
DK282384D0
DK282384D0 DK282384A DK282384A DK282384D0 DK 282384 D0 DK282384 D0 DK 282384D0 DK 282384 A DK282384 A DK 282384A DK 282384 A DK282384 A DK 282384A DK 282384 D0 DK282384 D0 DK 282384D0
Authority
DK
Denmark
Prior art keywords
antigen
procedures
preparing
vaccine containing
associated antigen
Prior art date
Application number
DK282384A
Other languages
English (en)
Other versions
DK282384A (da
Inventor
Shoshiro Asakura
Masakazu Adachi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of DK282384D0 publication Critical patent/DK282384D0/da
Publication of DK282384A publication Critical patent/DK282384A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/43—Protozoan antigens
    • A61K40/438—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK282384A 1983-06-10 1984-06-08 Malariaassocieret antigen, fremgangsmaade til fremstilling deraf og vaccine indeholdende antigenet DK282384A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58103901A JPS59227827A (ja) 1983-06-10 1983-06-10 マラリア原虫由来糖鎖関連抗原及びその製造法

Publications (2)

Publication Number Publication Date
DK282384D0 true DK282384D0 (da) 1984-06-08
DK282384A DK282384A (da) 1984-12-11

Family

ID=14366322

Family Applications (1)

Application Number Title Priority Date Filing Date
DK282384A DK282384A (da) 1983-06-10 1984-06-08 Malariaassocieret antigen, fremgangsmaade til fremstilling deraf og vaccine indeholdende antigenet

Country Status (13)

Country Link
US (1) US4643896A (da)
EP (1) EP0129173A3 (da)
JP (1) JPS59227827A (da)
KR (1) KR910002521B1 (da)
AU (1) AU565489B2 (da)
CA (1) CA1231051A (da)
DK (1) DK282384A (da)
ES (1) ES8600937A1 (da)
IL (1) IL71953A (da)
IN (1) IN160524B (da)
OA (1) OA07721A (da)
PH (1) PH21427A (da)
ZA (1) ZA844263B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767622A (en) * 1983-08-19 1988-08-30 University Of Illinois Method and materials for development of immunological responses protective against malarial infection
AU2384688A (en) * 1987-09-04 1989-03-31 Georgetown University Monoclonal antibodies to a plasmodium falciparum protein
IT1233419B (it) * 1987-12-11 1992-03-31 Eniricerche Spa Peptidi sintetici immunologicamente attivi utili per la preparazione di un vaccino antimalaria
US5264342A (en) * 1988-05-10 1993-11-23 Verigen, Inc. Method for determining the sensitivity and/or specificity of an assay system for detecting antibodies
FR2665909B1 (fr) * 1990-08-14 1992-11-13 Pasteur Institut Polypeptides de surface de globules rouges infectes par p. falciparum et compositions immunogenes les contenant.
JPH06502723A (ja) * 1990-11-09 1994-03-24 ヴェリジェン，インコーポレーテッド 抗体を検出する分析系の感度及び／又は特異性の決定方法
CN1176945C (zh) * 2001-02-01 2004-11-24 中国人民解放军第二军医大学 疟原虫融合抗原及其制法和用途
CA2967094C (en) * 2009-12-01 2022-08-16 Exthera Medical Corporation Method for removing cytokines from blood with surface immobilized polysaccharides
JP2017513636A (ja) 2014-04-24 2017-06-01 エクスセラ メディカル コーポレイション 高流量を用いて血液から細菌を除去するための方法
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
BR112021021141A2 (pt) 2019-05-16 2021-12-14 Exthera Medical Corp Método para modular estrutura glicocalyx endotelial

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2469457A (en) * 1945-09-17 1949-05-10 Univ Tennessee Res Corp Process for producing an antigen for use in the diagnosis of malaria and product thereof
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
IL65496A (en) * 1981-04-15 1985-10-31 Wellcome Found Protozoal antigen,its preparation and vaccine containing it
EP0071705B1 (en) * 1981-05-21 1989-11-23 The Wellcome Foundation Limited Protozoal antigen
GB2099300B (en) * 1981-05-21 1985-02-27 Wellcome Found Antigens from parasites of the genus plasmodium
US4416872A (en) * 1982-03-17 1983-11-22 The United States Of America As Represented By The Secretary Of The Army Treatment of malaria with liposomes containing 8-aminoquinoline derivatives and glycoconjugates

Also Published As

Publication number Publication date
KR850000247A (ko) 1985-02-26
IL71953A0 (en) 1984-09-30
EP0129173A3 (en) 1985-07-24
CA1231051A (en) 1988-01-05
ZA844263B (en) 1985-01-30
IL71953A (en) 1987-10-30
ES533250A0 (es) 1985-10-16
IN160524B (da) 1987-07-18
AU565489B2 (en) 1987-09-17
ES8600937A1 (es) 1985-10-16
AU2894884A (en) 1984-12-13
KR910002521B1 (ko) 1991-04-23
US4643896A (en) 1987-02-17
EP0129173A2 (en) 1984-12-27
JPS59227827A (ja) 1984-12-21
DK282384A (da) 1984-12-11
OA07721A (en) 1985-08-30
PH21427A (en) 1987-10-15

Similar Documents

Publication Publication Date Title
DK560784A (da) Hoejrenset protein, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende det
DK256485D0 (da) Veterinaert praeparat og fremgangsmaade til fremstilling deraf
DK276683A (da) Carbapenemer og fremgangsmaade til fremstilling deraf
DK260687D0 (da) Immunoglobulin-konjugater og fremgangsmaade til fremstilling deraf
DK163062C (da) Antigen, immunogen, proteinholdig vaccine imod coccidiose
DK282384D0 (da) Malariaassocieret antigen, fremgangsmaade til fremstilling deraf og vaccine indeholdende antigenet
DK58882A (da) Katalysator-forstadium til oxychlorering og fremgangsmaade til fremstilling heraf
DK196687A (da) Kombineret vaccine, samt fremgangsmaade til fremstilling deraf
ATE136903T1 (de) Impfstoff, der zecken-antigene enthält
DK592284D0 (da) Toxoid, vaccinepraeparat indeholdende det og fremgangsmaade til fremstilling af det
DK621484D0 (da) Acylaminomitosaner og fremgangsmaade til fremstilling deraf
DK155886D0 (da) Vaccine og fremgangsmaade til fremstilling af denne
DK343183D0 (da) Ketoquinoliner og fremgangsmade til fremstilling deraf
DK362987D0 (da) Hexahydroarylquinolizin og fremgangsmaade til fremstilling deraf
NO855106L (no) Bundet tekstilflatebilde og fremgangsmaate til fremstilling derav.
DK313687A (da) Fremgangsmaade til fremstilling af et antigen og vaccine indeholdende dette antigen
DK81192D0 (da) Substituerede ethandiimidamider og fremgangsmaade til fremstilling deraf
NO812115L (no) Fortilsetning, og fremgangsmaate for fremstilling derav.
DK552284A (da) 2-chlor-3-trifluormethylbenzaldehyd og fremgangsmaade til fremstilling deraf
DK454784D0 (da) 6-oxodecahydroquinoliner og fremgangsmaade til fremstilling heraf
DK454684A (da) 7beta-acylamino-3-azido-cephalosporiner og fremgangsmaade til fremstilling heraf
DK471783D0 (da) Farmaceutisk praeparat og fremgangsmade til fremstilling deraf
NO845134L (no) Dialkanoyloksybenzyliden-dialkanoat og fremgangsmaate til fremstilling derav.
DK372885D0 (da) Vaccine og fremgangsmaade til fremstilling heraf
DK284184D0 (da) 1-phenoxy-3-hydroxyindolylalkylamino-3-propanoler og fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment